Opdivo is a programmed death receptor-1 (PD-1) blocking antibody. The Food and Drug Administration (FDA) has expanded the approval of Opdivo ® (nivolumab) to include adjuvant treatment of patients 12 ...
The beneficial effects of glycoprotein IIb/IIIa receptor antagonists in preventing ischemic complications during percutaneous coronary intervention have been established in a series of controlled ...
NASA abandoned work toward piloted Mars and Venus flyby missions based on hardware developed for Apollo and its planned successor, the Apollo Applications Program, during the final months of the ...
JAXA: As a result of the successful launch of the H-IIB Launch Vehicle No. 3, the Japan Aerospace Exploration Agency (JAXA) and Mitsubishi Heavy Industries LTD. (MHI) have agreed to privatize the ...
RUC-4 (CeleCor Therapeutics), an investigational glycoprotein IIb/IIIa inhibitor (GPI) administered by subcutaneous injection, provides rapid and powerful platelet inhibition in patients with STEMI, ...
The International Investment Bank (IIB) says it will leave its headquarters in Budapest and return to Russia after the Hungarian government withdrew its representatives from the Moscow-led institution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results